Can next-generation antibodies offset biosimilar competition?
Asher
A
Mullard
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D017277:Drug Approval; D055808:Drug Discovery; D004345:Drug Industry / Q000191:economics / Q000639:trends; D005060:Europe; D006801:Humans; D007880:Legislation, Drug; D013810:Therapeutic Equivalency
D000911:Antibodies, Monoclonal